Add BrightSurf on Google Email

Loyola Medicine


Possible new blood test to diagnose heart attacks

Researchers have discovered a potential new biomarker for heart attacks, cardiac myosin binding protein-C (cMyBP-C), which is released into the blood following a heart attack. Elevated levels of cMyBP-C may help diagnose heart attacks more accurately, reducing unnecessary hospital admissions.

SourceLoyola Medicine·JournalJournal of Molecular and Cellular Cardiology·DateSep 20, 2011

Large waist doubles risk of kidney disease mortality

A study by Loyola University Health System researcher Holly Kramer found that a large waist circumference doubles the risk of dying among kidney disease patients. Waist circumference was more strongly linked to mortality than BMI, a commonly used measure of obesity.

SourceLoyola Medicine·JournalAmerican Journal of Kidney Diseases·DateJul 13, 2011

Another reason not to binge drink

A Loyola University Health System study found that binge drinking can change the body's immune system response to orthopaedic injury, complicating trauma care. This means that measuring chemical markers in the blood may be misleading when alcohol is involved.

SourceLoyola Medicine·JournalJournal of Bone and Joint Surgery·DateApr 15, 2011

Why are the elderly so vulnerable to pneunomia?

A study published in The Journal of Immunology reveals that the elderly are more susceptible to pneumonia and bacterial infections due to a decline in immune system cells. Researchers have found that macrophages and B cells, which fight bacteria, appear effective but are fewer in number, making them less effective. Developing targeted ...

SourceLoyola Medicine·JournalThe Journal of Immunology·DateMar 11, 2011

Experimental drug more potent, longer lasting than morphine

A new experimental drug, morphine-6-0-sulfate, has been found to be more potent and longer-lasting than standard morphine, with less likelihood of causing constipation. The study, led by Dr. Joseph Holtman Jr., tested the drug on rats and demonstrated its potential clinical advantages compared to morphine.

SourceLoyola Medicine·JournalEuropean Journal of Pharmacology·DateJan 3, 2011

Taking a break from osteoporosis drugs can protect bones

A recent study found that bone density remained stable for three years in patients who took a drug holiday from bisphosphonates, a popular class of osteoporosis drugs. The researchers recommend taking drug holidays after four to five years, but the study suggests that this duration may be longer, potentially up to three years.

How well does clot-busting drug work in stroke patients?

A study published in Archives of Neurology found that stroke patients who show improvement within one hour of receiving rt-PA are more likely to have a favorable outcome three months later. Researchers followed 120 patients and found that 68.2% had a favorable outcome, compared to 29.6% for those who did not show early improvement.

SourceLoyola Medicine·JournalArchives of Neurology·DateNov 9, 2010

Expensive new blood pressure meds no better than generics

A new study found that expensive brand-name medications for high blood pressure are no better than generic diuretics in preventing cardiovascular disease. The ALLHAT trial, which followed patients with high blood pressure for eight to 13 years, showed that the diuretic was superior in two measures: stroke death rate and hospitalization...

'Dawning of a new age' in bacteria research

Researchers at Loyola Medicine have discovered protein acetylation, a common molecular reaction in bacteria that affects protein function and gene regulation. This finding has significant implications for understanding bacterial physiology and developing new drugs to combat harmful bacteria.

SourceLoyola Medicine·JournalMolecular Microbiology·DateJul 12, 2010

How bacteria boost the immune system

Researchers discovered how bacteria aid digestion and enhance immune function by binding to B lymphocytes. This finding suggests the possibility of using bacterial spores to treat people with weakened or undeveloped immune systems.

SourceLoyola Medicine·JournalThe Journal of Immunology·DateJun 14, 2010

Surgical options for female incontinence found to be effective but with different complications

Two surgical techniques for female stress incontinence were found to be equivalent in efficacy but differed in side effects. The retropubic procedure had a higher rate of urinary dysfunction requiring surgery compared to the transobturator procedure. These findings will help guide care for women undergoing stress-incontinence surgery.

SourceLoyola Medicine·JournalNew England Journal of Medicine·DateMay 17, 2010

Tapeworm brain infection 'serious health concern'

Neurocysticercosis, a tapeworm brain infection, is increasing in Mexico and bordering southwestern US states, affecting up to 10% of the population. The infection can cause severe symptoms like seizures, headaches, and encephalitis, highlighting the need for proper evaluation and management.

SourceLoyola Medicine·JournalNeurological Research·DateApr 13, 2010

How estrogen feeds breast tumors

Researchers found that estrogen inhibits MLK3, a protein that causes normal cell death, leading to uncontrolled growth of cancer cells and resistance to chemotherapy. This discovery could lead to new cancer-fighting drugs.

SourceLoyola Medicine·JournalCancer Research·DateMar 2, 2010